2025-03-29 04:44:45
Latest Post
Unifinz Capital India Limited declares interim dividend of Rs. 0.50
Suprajit Completes Second Tranche of SCS Acquisition
Ceigall Ayodhya Bypass Pvt Ltd receives appointed date from NHAI
Lemon Tree Hotels signs a new property in Maharashtra
Karur Vysya Bank inaugurates 4 new branches today, 3 in TN and 1 in AP
Stock Report
Hester Biosciences Limited Q4 FY2024 consolidated profit increases to Rs. 4.95 crore
Posted On : 2024-05-11 07:34:58( TIMEZONE : IST )
Hester Biosciences Limited has reported Consolidated financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 83.40 crores during the period ended March 31, 2024 as compared to Rs. 67.973 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 4.95 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 3.984 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 7.52 for the period ended March 31, 2024 as compared to Rs. 4.73 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹ 83.40 crs | ₹67.973 crs |  22.70% |
| Net Profit | ₹4.95 crs | ₹3.984 crs | 24.25% |
| EPS | ₹7.52 | ₹4.73 | 58.99% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs. 83.40 crores during the period ended March 31, 2024 as compared to Rs.70.487 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.4.95 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.4.531 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.7.52 for the period ended March 31, 2024 as compared to Rs.6.72 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹ 83.40 crs | ₹70.487 crs | 18.32% |
| Net Profit | ₹4.95 crs | ₹4.531 crs | 9.25% |
| EPS | ₹7.52 | ₹6.72 | 11.90% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.315.184 crores during the Financial Year ended March 31, 2024 as compared to Rs.281.242 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.18.889 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.26.627 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.24.88 for the Financial Year ended March 31, 2024 as compared to Rs.32.96 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹315.184 crs | ₹281.242 crs | 12.07% |
| Net Profit | ₹18.889 crs | ₹26.627 crs |  -29.06% |
| EPS | ₹24.88 | ₹32.96 | -24.51% |
Shares of Hester Biosciences Limited was last trading in BSE at Rs. 1673.85 as compared to the previous close of Rs. 1655.15. The total number of shares traded during the day was 285 in over 82 trades.
The stock hit an intraday high of Rs. 1690.00 and intraday low of 1641.55. The net turnover during the day was Rs. 472740.00.
